Health benefits of sesamin on cardiovascular disease and its associated risk factors.

Saudi Pharm J · 2020 · PMC7584802 · PMID 33132721

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Thus, the slight reduction of systolic and diastolic blood pressure by sesamin may be significant enough to decrease the risk of developing CVDs ( Miyawaki et al., 2009 ).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.